Verastem
The Associate Director, Quality GCP is responsible for developing and implementing quality programs and risk-based GCP strategies across clinical studies. This role involves managing audits, leading investigations of quality events, and ensuring inspection readiness while collaborating with internal and external stakeholders. The position also focuses on driving process improvements and providing GCP guidance to support clinical operations.
Headquarters
Needham Heights, Massachusetts, United States
Company Size
51-200 employees
Founded
2010
Verastem Oncology is a biopharmaceutical company focused on developing and delivering novel therapies for RAS/MAPK pathway-driven cancers. The company has advanced the first FDA-approved treatment for KRAS-mutant recurrent low-grade serous ovarian cancer and maintains a pipeline of small molecule inhibitors targeting KRAS G12D, RAF/MEK, and FAK pathways. Verastem leverages strategic collaborations and ongoing clinical trials to address significant unmet needs across multiple solid tumor types.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Verastem.
Associate Director GCP Quality
Kiniksa Pharmaceuticals
Director, Quality Assurance GCP
Crinetics Pharmaceuticals
Senior Manager, Clinical Compliance & Inspection Readiness
Olema Oncology
Manager Quality (GCP)
MoonLake Immunotherapeutics
Director Quality GCP
Monte Rosa Therapeutics, Inc
Associate Director, GCP Quality Oversight
Madrigal Pharmaceuticals